Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules

Tissue Antigens

Volumn 70, Issue 1, 2007, Pages 42-52

  Hansen, B E ^a,b   Rasmussen, A H ^a   Jakobsen, B K ^a   Ryder, L P ^a   Svejgaard, A ^a  

^a Rigshospitalet   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

Author keywords

Antigen presentation; Autoimmunity; Cross reactivity; HLA class II; MHC; Mimicry; Multiple sclerosis; Myelin basic protein; Peptide binding; T cell hybridoma; T cells; TCR specificity

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL TRANSFORMATION; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL;

AUTOIMMUNITY; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; CROSS REACTIONS; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; HYBRIDOMAS; MOLECULAR MIMICRY; PEPTIDES; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL;

EID: 34249998441     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2007.00849.x     Document Type: Article

References (27)

1. Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu Rev Immunol 2003 : 21 : 139 76.
2. Sospedra M, Martin R. Molecular mimicry in multiple sclerosis. Autoimmunity 2006 : 39 : 3 8.
3. Svejgaard A. MHC and disease associations. In : Herzenberg LA, Herzenberg LA, eds. Weir's Handbook of Experimental Immunology in Four Volumes, 5th edn, Chapter 37. New York : Blackwell Scientific Publications, 1996, 37.1 37.13.
4. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005 : 23 : 683 747.
5. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA. T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis. Nature 1990 : 346 : 183 7.
6. Wucherpfennig KW, Zhang J, Witek C et al. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 1994 : 152 : 5581 92.
7. Wucherpfennig KW, Sette A, Southwood S et al. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med 1994 : 179 : 279 90.
8. Lang HLE, Jacobsen H, Ikemizu S et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 2002 : 3 : 940 3.
9. Mycko MP, Waldner H, Anderson DE et al. Cross-reactive TCR responses to self antigens presented by different MHC class II molecules. J Immunol 2004 : 173 : 1689 98.
10. Hahn M, Nicholson M, Pyrdol J, Wucherpfennig K. Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat Immunol 2005 : 6 : 490 6.
11. Nicholson MJ, Hahn M, Wucherpfennig KW. Unusual features of self-peptide/MHC binding by autoimmune T cell receptors. Immunity 2005 : 23 : 351 60.
12. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995 : 80 : 695 705.
13. Madsen L, Andersson EC, Jansson L et al. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet 1999 : 23 : 343 7.
14. Kalandadze A, Galleno M, Foncerrada L, Strominger JL, Wucherpfennig KW. Expression of recombinant HLA-DR2 molecules. Replacement of the hydrophobic transmembrane region by a leucine zipper dimerization motif allows the assembly and secretion of soluble DR alpha beta heterodimers. J Biol Chem 1996 : 271 : 20156 62.
15. Hansen BE, Andersson EC, Madsen LS et al. Functional characterization of HLA-DRA1*0101/DRB1*0401 molecules expressed in Drosophila melanogaster cells. Tissue Antigens 1998 : 5 : 119 28.
16. Li Y, Li H, Martin R, Mariuzza RA. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins. J Mol Biol 2000 : 304 : 177 88.
17. Doherty DG, Penzotti JE, Koelle DM et al. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR. J Immunol 1998 : 161 : 3527 35.
18. Udaka K, Tsomides TJ, Eisen HN. A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein. Cell 1992 : 69 : 989 98.
19. Hennecke J, Wiley DC. Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. J Exp Med 2002 : 195 : 571 81.
20. Sospedra M, Muraro PA, Stefanova I et al. Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype. J Immunol 2006 : 176 : 1951 61.
21. Sykulev Y, Brunmark A, Tsomides TJ et al. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc Natl Acad Sci U S A 1994 : 91 : 11487 91.
22. Basu D, Horvath S, Matsumoto I, Fremont DH, Allen PM. Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR. J Immunol 2000 : 164 : 5788 96.
23. Brock R, Wiesmuller KH, Jung G, Walden P. Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor. Proc Natl Acad Sci U S A 1996 : 93 : 13108 13.
24. Whitelegg A, Barber LD. The structural basis of T-cell allorecognition. Tissue Antigens 2004 : 63 : 101 8.
25. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 2006 : 24 : 419 66.
26. Larche M, Wraith DC. Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 2005 : 11 : S69 76.
27. Gregersen JW, Kranc KR, Ke X et al. Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature 2006 443 : 574 77.